U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. ALYGLO
  1. Approved Blood Products

STN: 125743
Proper Name: immune globulin intravenous human-stwk
Tradename: ALYGLO
Manufacturer: GC Biopharma Corp.

Indication:

  • Indicated for the treatment of primary humoral immunodeficiency (PI) in adults.

Production Information

  • Package Insert - ALYGLO
  • Demographic Subgroup Information- immune globulin intravenous, human-stwk, ALYGLO
    Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Back to Top